Within a new study, we claimed the identification as well as characterization of a new atypical opioid receptor with exclusive detrimental regulatory Houses to opioid peptides.1 Our outcomes showed that ACKR3/CXCR7, hitherto referred to as an atypical scavenger receptor for chemokines CXCL12 and CXCL11, is likewise a wide-spectrum scavenger for opi